NCT06510413View on ClinicalTrials.gov

An Bioequivalence Study of Loxoprofen Sodium Patches in Healthy Volunteers

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2024

Primary Completion Date

August 31, 2024

Study Completion Date

August 31, 2024

Conditions
OsteoarthritisMuscle PainSwelling Muscle
Interventions
DRUG

Loxoprofen Sodium Patches(reference product)

Single dose of one patch in each period; Apply for 24 hours each time

DRUG

Loxoprofen Sodium Patches(test product )

Single dose of one patch in each period; Apply for 24 hours each time

Sponsors
All Listed Sponsors
lead

Frontier Biotechnologies Inc.

INDUSTRY